Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05204082 · ClinicalTrials.gov registry record · NA
A Study to Evaluate SU-VEID™ for Improving Peripheral Venous Access Success in Children
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 169
- Enrollment target
NCT05204082: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT05204082 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 169 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05204082, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 169 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if use of the SU-VEID™ in children facilitates an increase success rate of peripheral intravenous starts, in comparison to the conventional method of vein entry techniques.
Primary Outcome
Percentage of participants to have an IV access within the first attempt when using the SU-VEID Device in comparison to the conventional procedure
Interventions
- DEVICE Single Use Vein Entry Indicator Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2022-03-28 |
| Est. Completion | 2022-07-21 |
| Phase | NA |
Why NCT05204082 stopped before completion
NCT05204082 is an interventional study that assigns participants to a tested intervention. The registered 169 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which Single Use Vein Entry Indicator Device is the first listed.
NCT05204082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05204082 about?
NCT05204082 is a clinical study titled "A Study to Evaluate SU-VEID™ for Improving Peripheral Venous Access Success in Children". The purpose of this study is to determine if use of the SU-VEID™ in children facilitates an increase success rate of peripheral intravenous starts, in comparison to the conventional method of vein entry techniques.
What is the current status of trial NCT05204082?
This trial is currently terminated. It is a NA study. The enrollment target is 169 participants. The study started on 2022-03-28. Estimated completion is 2022-07-21.
What interventions are being tested in trial NCT05204082?
The interventions under investigation include: Single Use Vein Entry Indicator Device (DEVICE).
Who is sponsoring clinical trial NCT05204082?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05204082's enrollment target sits among peer trials
169 619th of 2000 higher than 1,382 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06191484 · 169 participants · NA
Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI